Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 31-Jul-24 4:05 PM View:  | Viking Therapeutics, Inc. (VKTX) | 30-Jul-24 | Sale | 16,136 | $57.15 | $922,212.00 | (8%) 203.19K to 187.05K | |
| 31-Jul-24 4:05 PM View: | Viking Therapeutics, Inc. (VKTX) | 29-Jul-24 | Grant | 28,334 | -- | -- | 16% 174.85K to 203.19K | |
| 03-May-24 8:51 PM View: | Viking Therapeutics, Inc. (VKTX) | 03-May-24 | Option Exercise | 34,249 | $4.86 | $166,285.00 | 17% 207.36K to 241.61K | |
| 03-May-24 8:51 PM View: | Viking Therapeutics, Inc. (VKTX) | 03-May-24 | Planned Option Sale | 34,249 | $74.69 | $2,558,060.00 | (14%) 241.61K to 207.36K | |
| 03-May-24 8:51 PM View: | Viking Therapeutics, Inc. (VKTX) | 03-May-24 | Sale (Planned) | 32,507 | $74.69 | $2,427,950.00 | (16%) 207.36K to 174.85K | |
| 27-Mar-24 8:50 PM View: | Viking Therapeutics, Inc. (VKTX) | 27-Mar-24 | Grant | 31,667 | -- | -- | 16% 192.3K to 223.97K | |
| 27-Mar-24 8:50 PM View: | Viking Therapeutics, Inc. (VKTX) | 27-Mar-24 | Payment of Exercise | 16,610 | $83.34 | $1,384,280.00 | (7%) 223.97K to 207.36K | |
| 04-Mar-24 7:50 PM View: | Viking Therapeutics, Inc. (VKTX) | 01-Mar-24 | Grant | 31,667 | -- | -- | 18% 180.73K to 212.4K | |
| 04-Mar-24 7:50 PM View: | Viking Therapeutics, Inc. (VKTX) | 01-Mar-24 | Payment of Exercise | 20,093 | $85.22 | $1,712,330.00 | (9%) 212.4K to 192.3K | |
| 04-Jan-24 9:35 PM View: | Viking Therapeutics, Inc. (VKTX) | 04-Jan-24 | Payment of Exercise | 13,872 | $18.58 | $257,742.00 | (7%) 209.6K to 195.73K | |
| 04-Jan-24 9:35 PM View: | Viking Therapeutics, Inc. (VKTX) | 04-Jan-24 | Sale | 15,000 | $17.90 | $268,500.00 | (8%) 195.73K to 180.73K | |
| 04-Jan-24 9:35 PM View: | Viking Therapeutics, Inc. (VKTX) | 03-Jan-24 | Grant | 98,334 | -- | -- | 61% 160.39K to 258.72K | |
| 04-Jan-24 9:35 PM View: | Viking Therapeutics, Inc. (VKTX) | 03-Jan-24 | Payment of Exercise | 49,122 | $17.40 | $854,723.00 | (19%) 258.72K to 209.6K | |
| 18-Apr-23 7:07 PM View: | Viking Therapeutics, Inc. (VKTX) | 17-Apr-23 | Option Exercise | 7,500 | $13.07 | $98,025.00 | 5% 149.28K to 156.78K | |
| 18-Apr-23 7:07 PM View: | Viking Therapeutics, Inc. (VKTX) | 17-Apr-23 | Planned Option Sale | 7,500 | $20.00 | $150,000.00 | (5%) 156.78K to 149.28K | |
| 13-Apr-23 5:13 PM View: | Viking Therapeutics, Inc. (VKTX) | 12-Apr-23 | Option Exercise | 41,544 | $5.99 | $249,026.00 | 28% 149.28K to 190.82K | |
| 13-Apr-23 5:13 PM View: | Viking Therapeutics, Inc. (VKTX) | 12-Apr-23 | Planned Option Sale | 41,544 | $18.00 | $747,792.00 | (22%) 190.82K to 149.28K | |
| 13-Apr-23 5:13 PM View: | Viking Therapeutics, Inc. (VKTX) | 11-Apr-23 | Option Exercise | 56,295 | $5.25 | $295,778.00 | 38% 149.28K to 205.57K | |
| 13-Apr-23 5:13 PM View: | Viking Therapeutics, Inc. (VKTX) | 11-Apr-23 | Planned Option Sale | 56,295 | $18.00 | $1,013,520.00 | (27%) 205.57K to 149.28K | |
| 03-Apr-23 7:24 PM View: | Viking Therapeutics, Inc. (VKTX) | 03-Apr-23 | Grant | 56,667 | -- | -- | 38% 147.78K to 204.44K | |
| 03-Apr-23 7:24 PM View: | Viking Therapeutics, Inc. (VKTX) | 03-Apr-23 | Payment of Exercise | 55,166 | $17.57 | $969,267.00 | (23%) 235.36K to 180.19K | |
| 03-Apr-23 7:24 PM View: | Viking Therapeutics, Inc. (VKTX) | 03-Apr-23 | Option Exercise | 30,911 | $7.77 | $240,178.00 | 15% 204.44K to 235.36K | |
| 03-Apr-23 7:24 PM View: | Viking Therapeutics, Inc. (VKTX) | 03-Apr-23 | Planned Option Sale | 30,911 | $18.00 | $556,398.00 | (17%) 180.19K to 149.28K | |
| 03-Apr-23 7:24 PM View: | Viking Therapeutics, Inc. (VKTX) | 30-Mar-23 | Option Exercise | 93,750 | $7.29 | $683,482.00 | 51% 185.06K to 278.81K | |
| 03-Apr-23 7:24 PM View: | Viking Therapeutics, Inc. (VKTX) | 30-Mar-23 | Planned Option Sale | 93,750 | $17.00 | $1,593,980.00 | (34%) 278.81K to 185.06K | |
| 03-Apr-23 7:24 PM View: | Viking Therapeutics, Inc. (VKTX) | 30-Mar-23 | Sale (Planned) | 37,279 | $17.00 | $633,836.00 | (20%) 185.06K to 147.78K | |
| 04-Jan-23 6:25 PM View: | Viking Therapeutics, Inc. (VKTX) | 04-Jan-23 | Payment of Exercise | 20,708 | $8.42 | $174,361.00 | (10%) 205.76K to 185.06K | |
| 04-Jan-23 6:25 PM View: | Viking Therapeutics, Inc. (VKTX) | 03-Jan-23 | Grant | 90,667 | -- | -- | 65% 139.03K to 229.7K | |
| 04-Jan-23 6:25 PM View: | Viking Therapeutics, Inc. (VKTX) | 03-Jan-23 | Payment of Exercise | 23,933 | $8.52 | $203,909.00 | (10%) 229.7K to 205.76K | |
| 04-Jan-23 6:25 PM View: | Viking Therapeutics, Inc. (VKTX) | 30-Dec-22 | Grant | 20,233 | -- | -- | 15% 138.5K to 158.73K | |
| 04-Jan-23 6:25 PM View: | Viking Therapeutics, Inc. (VKTX) | 30-Dec-22 | Payment of Exercise | 19,697 | $9.40 | $185,152.00 | (12%) 158.73K to 139.03K | |
| 05-Jan-22 7:13 PM View: | Viking Therapeutics, Inc. (VKTX) | 04-Jan-22 | Payment of Exercise | 8,835 | $4.62 | $40,817.70 | (6%) 145.14K to 136.3K | |
| 05-Jan-22 7:13 PM View: | Viking Therapeutics, Inc. (VKTX) | 03-Jan-22 | Grant | 53,333 | -- | -- | 56% 94.9K to 148.24K | |
| 05-Jan-22 7:13 PM View: | Viking Therapeutics, Inc. (VKTX) | 03-Jan-22 | Payment of Exercise | 3,097 | $4.88 | $15,113.40 | (2%) 148.24K to 145.14K | |
| 30-Sep-21 5:43 PM View: | Viking Therapeutics, Inc. (VKTX) | 28-Sep-21 | Grant | 6,667 | -- | -- | 7% 90.12K to 96.79K | |
| 30-Sep-21 5:43 PM View: | Viking Therapeutics, Inc. (VKTX) | 28-Sep-21 | Payment of Exercise | 2,306 | $6.50 | $14,989.00 | (2%) 96.79K to 94.48K | |
| 19-Jan-21 6:25 PM View: | Viking Therapeutics, Inc. (VKTX) | 19-Jan-21 | Payment of Exercise | 808 | $6.68 | $5,397.44 | (< 1%) 90.56K to 89.75K | 3% |
| 06-Jan-21 4:28 PM View: | Viking Therapeutics, Inc. (VKTX) | 04-Jan-21 | Grant | 71,450 | -- | -- | 326% 21.9K to 93.35K | |
| 06-Jan-21 4:28 PM View: | Viking Therapeutics, Inc. (VKTX) | 04-Jan-21 | Payment of Exercise | 2,787 | $5.80 | $16,164.60 | (3%) 93.35K to 90.56K | |
| 19-Feb-08 6:03 PM View: | Sangamo Biosciences Inc. (SGMO) | 14-Feb-08 | Option Exercise | 5,000 | $4.97 | $24,825.70 | 722% 0.69K to 5.69K | |
| 12-Mar-08 7:41 PM View: | Sangamo Biosciences Inc. (SGMO) | 14-Feb-08 | Option Exercise | 100 | $4.11 | $411.00 | 14% 0.69K to 0.79K | 149% |
| 19-Feb-08 6:03 PM View: | Sangamo Biosciences Inc. (SGMO) | 14-Feb-08 | Market Option Sale (Planned) | 5,000 | $12.02 | $60,095.00 | (88%) 5.69K to 0.69K | (36%) |
| 12-Mar-08 7:41 PM View: | Sangamo Biosciences Inc. (SGMO) | 14-Feb-08 | Market Option Sale (Planned) | 100 | $12.00 | $1,200.00 | (13%) 0.79K to 0.69K | (36%) |
| 10-Jan-08 6:13 PM View: | Sangamo Biosciences Inc. (SGMO) | 08-Jan-08 | Option Exercise | 5,000 | $4.78 | $23,920.10 | 722% 0.69K to 5.69K | |
| 10-Jan-08 6:13 PM View: | Sangamo Biosciences Inc. (SGMO) | 08-Jan-08 | Market Option Sale (Planned) | 5,000 | $12.87 | $64,370.00 | (88%) 5.69K to 0.69K | (27%) |
| 11-Dec-07 6:07 PM View: | Sangamo Biosciences Inc. (SGMO) | 07-Dec-07 | Option Exercise | 5,000 | $4.38 | $21,886.50 | 722% 0.69K to 5.69K | |
| 11-Dec-07 6:07 PM View: | Sangamo Biosciences Inc. (SGMO) | 07-Dec-07 | Market Option Sale (Planned) | 5,000 | $15.80 | $78,994.50 | (88%) 5.69K to 0.69K | (3%) |
| 13-Nov-07 6:03 PM View: | Sangamo Biosciences Inc. (SGMO) | 08-Nov-07 | Option Exercise | 11,858 | $3.76 | $44,573.90 | 1847% 0.64K to 12.5K | |
| 13-Nov-07 6:03 PM View: | Sangamo Biosciences Inc. (SGMO) | 08-Nov-07 | Market Option Sale | 11,858 | $18.03 | $213,800.00 | (95%) 12.5K to 0.64K | 10% |
| 13-Nov-07 6:03 PM View: | Sangamo Biosciences Inc. (SGMO) | 08-Nov-07 | Market Sale | 642 | $18.03 | $11,575.30 | (100%) 0.64K to 0 | 10% |